Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel.

Kapur N, Mir H, Sonpavde GP, Jain S, Bae S, Lillard JW, Singh S. Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel. Cancer Lett. 2019 07 10; 454:1-13.

View in: PubMed

subject areas

Amyloid Precursor Protein Secretases
Antibodies, Monoclonal
Antineoplastic Agents
Apoptosis
Cell Line, Tumor
Drug Resistance, Neoplasm
Drug Synergism
Humans
Male
Membrane Proteins
NF-kappa B
Prostatic Neoplasms
Signal Transduction

authors with profiles

Hina Mir
James Lillard
Shailesh Singh

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support